West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...
EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...
Fifth Third Bancorp lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 2.0% ...
The company delivered a trailing four-quarter average earnings surprise of 8.04%. West Pharmaceutical delivered better-than-expected third-quarter results, signaling resilience and recovery ...
Zacks.com on MSN11d
Reasons to Hold West Pharmaceutical Stock in Your Portfolio NowWest Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and ...
CHARLESTON, W.Va. — West Virginia looks to receive as much as $55 million from the announced $74 billion dollar settlement ...
West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years
But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of West Pharmaceutical Services, Inc. (NYSE:WST) stock is up an impressive 121% over ...
West Pharmaceutical Services Inc. closed 16.68% below its 52-week high of $413.70, which the company achieved on February 7th.
West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years
But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of West Pharmaceutical Services, Inc. (NYSE:WST) stock is up an impressive 121% over the ...
and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback